LEXICON PHARMACEUTICALS INC

$LXRX
Smart money positioned

5 of the Top-200 alpha managers hold $LXRX as of the latest 13F snapshot.

13F holders
135
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

5 holders · Q1 2026

$LXRX is held by 5 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.07%, with an average of 0.03% of portfolio. Largest holder: ADAR1 Capital Management, LLC at 0.07%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 135 · Source: 13F-HR
01
Lvm Capital Management LTD
23.89% of portfolio
154,734,327 sh
02
GSG Advisors LLC
1.92% of portfolio
44,303,518 sh
03
Oakworth Capital, Inc.
0.51% of portfolio
17,912,961 sh
04
Northeast Financial Consultants Inc
0.02% of portfolio
15,629,212 sh
05
Exor N.V.
10,199,382 sh
06
Evergreen Capital Management LLC
4,944,731 sh
07
RE Dickinson Investment Advisors, LLC
3,600,000 sh
08
Minneapolis Portfolio Management Group, LLC
2,238,848 sh
09
Flow State Investments, L.P.
0.05% of portfolio
1,696,276 sh
10
Brightline Capital Management, LLC
1,682,100 sh
See all 135 13F holders · Pro →

Insider activity · last 90 days

1 transactions · 1 filers
23 Feb 2026
Debbane Raymond
▲ BOUGHT
100,000
$1.47
P

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $LXRX in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 13:46 UTC.